Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NantCell

NantCell?uq=8lCq2teR
2014 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$9.2M LATEST DEAL AMOUNT
Description

Developer of molecular-level cell-based treatments. The company develops immunology based treatments and drugs for the treatment of cancer and auto-immune diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 9920 Jeffersoon Boulvard
  • Culver City, CA 90232
  • United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NantCell’s full profile, request a free trial.

NantCell Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 14-Apr-2017 $9.2M 00000 Completed Startup
1. Undetermined 21-Jan-2016 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NantCell Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000000 01-Aug-2017 000000000000000000 000 Biotechnology 0000000 0000-000000
00000000000 23-Mar-2017 000000000000000000 00.00 Biotechnology 0000000 0000-000000
0000000 01-Jan-2016 000000000000000000 Other Devices and Supplies
Etubics 01-Oct-2015 Later Stage VC 0000 Other Devices and Supplies
To view this company’s complete investment and acquisition history, request access »

NantCell Subsidiaries (3)

Company Name Industry Location Founded
Etubics Other Devices and Supplies Seattle, WA 2003
00000 0000000000 Biotechnology Miramar, FL 0000
00000000000 Biotechnology Louisville, CO 0000
To view this company’s complete subsidiary history, request access »

NantCell Executive Team (1)

Name Title Board
Seat
Contact
Info
Patrick Soon-Shiong Founder & Chief Executive Officer